Expression and significance of angiogenesis-related factors in liver fibrosis model of Budd-Chiari syndrome in rats
朱楠,张甜甜,刘宝来,吕维富,成德雷,方伟伟
DOI: https://doi.org/10.3760/cma.j.cn421213-20200727-01607
2021-01-01
Abstract:Objective:To explore the expression and significance of angiogenesis-related factors in liver fibrosis model of budd-chiari syndrome (BCS) in rats.Methods:The animal model of BCS was established by partially ligating the inferior vena cava in rats. All animals were divided into control group (20 rats), experimental group (80 rats) and sham group (80 rats). The experimental group and sham group were divided into four subgroups (1, 3, 6, 12 weeks) of 20 rats each. After the experiment, liver tissues in each group were collected for immunohistochemistry, hematoxylin and eosin (HE), and Masson staining. The levels of endothelin (ET)-1, vascular endothelial growth factor (VEGF), inducible nitric oxide synthase (iNOS) and angiopoietin (Angpt)-1 were examined respectively. Variance analysis was used to analyze the differences of each factor level among groups. LSD test was used for multiple comparisons among subgroups. Pearson method and Spearman method were used for correlation analysis.Results:The mRNA expression of VEGF (1.41±0.18, 6.54±0.78, 4.19±0.41, 2.16±0.25), iNOS (2.06±0.21, 8.88±0.95, 4.85±0.51, 2.79±0.28) and Angpt-1 (9.57±0.91, 6.20±1.39, 4.53±0.49, 2.55±0.33) were compared between control group and sham group respectively, and the overall difference was not statistically significant (VEGF: F=0.487, P>0.05; iNOS: F=0.651, P>0.05; Angpt-1: F=0.969, P>0.05); the overall difference was statistically significant in the experimental group compared with the control group and the sham group (VEGF: F=366.124, 412.266; iNOS: F=443.326, 1170.864; Angpt-1: F=213.868, 503.210, P<0.01); the expression of each factor in the subgroups of experimental group was higher than that of control group (VEGF: 0.97±0.08; iNOS: 1.01±0.11; Angpt-1: 1.01±0.10) and sham subgroups at the same time ( P<0.05). The overall differences of mRNA expression of VEGF (1.41±0.18, 6.54±0.78, 4.19±0.41, 2.16±0.25), iNOS (2.06±0.21, 8.88±0.95, 4.85±0.51, 2.79±0.28) and Angpt-1 (9.57±0.91, 6.20±1.39, 4.53±0.49, 2.55±0.33) in the experimental group at each time point after the operation were significant ( F=293.799, 346.260, 137.121, P<0.01), and the comparison between each subgroup were also statistically significant ( P<0.05). VEGF (1.41±0.18, 6.54±0.78, 4.19±0.41, 2.16±0.25) was positively correlated with iNOS (2.06±0.21, 8.88±0.95, 4.85±0.51, 2.79±0.28) and angpt-1 (9.57±0.91, 6.20±1.39, 4.53±0.49, 2.55±0.33, r=0.983, 0.364, P<0.05), and iNOS (2.06±0.21, 8.88±0.95, 4.85±0.51, 2.79±0.28) was positively correlated with angpt-1 (9.57±0.91, 6.20±1.39, 4.53±0.49, 2.55±0.33, r=0.377, P<0.05). Conclusion:The expression of iNOS, Angpt-1 and VEGF in BCS model is increased and positively correlated each other. They are involved in the regulation of intrahepatic and extrahepatic angiogenesis and liver fibrosis in BCS, but the specific mechanism needs further study.